Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)
- Citation:
- Br J Clin Pharmacol vol 78 (5) 1005-13
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Xiaofeng Wang was also supported in part by a University of Iowa Presidential Fellowship.
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- 1005
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, CA33601, CA41287, CA03927, U10 CA180821, CA16450, CA77440, CA04326, U10 CA180882, U24 CA196171, CA47642, CA31946
- Corr. Author:
- Authors:
- Xiaofeng Wang Kouros Owzar Pankaj Gupta Richard A Larson Flora Mulkey Antonius A Miller Lionel D Lewis David Hurd Ravi Vij Mark J Ratain Daryl J Murry
- Networks:
- Study
- CALGB-10105
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- autoinduction, population pharmacokinetic model, time-dependent clearance, vatalanib